Retrocausal, a Seattle, WA-based startup that uses AI technology to help manufacturers and their employees has raised $5.3 million in an investment, bringing its total funding to $9.75 million. SaaS Investors The round was led by Glasswing Ventures, One Way Ventures, and Indicator Ventures, with participation from Argon Ventures, Differential …

Rich Data Co (RDC), a Sydney, Australia-based provider of AI decisioning platform assisting banks in making lending decisions, raised $17.5 million in its Series B funding round. SaaS Investors The investment was led by Westpac and nCino, with participation from BMYG and Octava Fund. Westpac is Australia’s bank and company …

Brightside AI, a Prilly, Switzerland-based company that provides a SaaS platform to help teams combat social-engineering cyberattacks, has secured $1 million in funding. SaaS Investors The investment was from Social Links. Social Links is a global OSINT (Open source intelligence) vendor with HQ in the US that empowers investigators and …

Quartix, a Charlotte, NC-based fintech company dedicated to bringing Supply Chain Finance (SCF) solutions to mid-market industrial clients, has secured $15 million in funding and a new credit facility that can scale up to $50M. SaaS Investors The round was led by SR Alternative Credit (SRAC), a U.S.-based private credit …

Letterhead, a Miami, FL-based platform that automates the creation and management of email newsletters, has closed a $5.3 million seed funding. SaaS Investors The round was led by Las Olas Venture Capital and Reign Ventures, with participation from BDMI, Florida Opportunity Fund, and McClatchy. Las Olas Venture Capital (LOVC) is …

Revela, a Detroit, MI-based property management solution, has raised $9 million in Series A funding. SaaS Investors The round was led by FirstMark Capital, with participation from Detroit Venture Partners, MetaProp, and Assurant Ventures. Founded in 2008, FirstMark Capital is a venture capital firm based in New York, New York. …

Biolexis Therapeutics, an American Fork, UT-based clinical-stage AI-driven drug discovery company, closed a $10 million Series A funding. SaaS Investors The round was led by Clarke Capital. Clarke Capital is an alternative asset investment firm with a robust portfolio of successful companies. Clarke takes a "hands on" approach when partnering …